首页> 外文期刊>Science >2.3 angstrom resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition
【24h】

2.3 angstrom resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition

机译:2.3人p97的冷冻分辨率EM结构和变构抑制机制

获取原文
获取原文并翻译 | 示例
       

摘要

p97 is a hexameric AAA+ adenosine triphosphatase (ATPase) that is an attractive target for cancer drug development. We report cryo-electron microscopy (cryo-EM) structures for adenosine diphosphate (ADP)-bound, full-length, hexameric wild-type p97 in the presence and absence of an allosteric inhibitor at resolutions of 2.3 and 2.4 angstroms, respectively. We also report cryo-EM structures (at resolutions of similar to 3.3, 3.2, and 3.3 angstroms, respectively) for three distinct, coexisting functional states of p97 with occupancies of zero, one, or two molecules of adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S) per protomer. A large corkscrew-like change in molecular architecture, coupled with upward displacement of the N-terminal domain, is observed only when ATPgS is bound to both the D1 and D2 domains of the protomer. These cryo-EM structures establish the sequence of nucleotide-driven structural changes in p97 at atomic resolution. They also enable elucidation of the binding mode of an allosteric small-molecule inhibitor to p97 and illustrate how inhibitor binding at the interface between the D1 and D2 domains prevents propagation of the conformational changes necessary for p97 function.
机译:p97是六聚体AAA +腺苷三磷酸酶(ATPase),是开发癌症药物的诱人靶标。我们报告冷冻电子显微镜(cryo-EM)结构的磷酸腺苷二磷酸(ADP)绑定,全长,六聚体野生型p97在存在和不存在变构抑制剂分别在2.3和2.4埃的分辨率。我们还报告了p97的三个不同的,共存的功能状态的冷冻电磁结构(分别类似于3.3、3.2和3.3埃的分辨率),其占据的腺苷5'-O-(为零,一个或两个分子)每个protomer(3-硫代三磷酸)(ATPγS)。仅当ATPgS既与原发者的D1和D2结构域结合时,也观察到分子结构发生大的类似于开瓶器的变化,并伴随着N末端结构域的向上移位。这些低温电磁结构以原子分辨率建立了p97中核苷酸驱动的结构变化的序列。它们还能够阐明变构小分子抑制剂与p97的结合模式,并说明抑制剂在D1和D2域之间的界面处的结合如何阻止p97功能必需的构象变化的传播。

著录项

  • 来源
    《Science》 |2016年第6275期|871-875|共5页
  • 作者单位

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

    Univ Calif San Francisco, Sch Pharm, Small Mol Discovery Ctr, Pharmaceut Chem, San Francisco, CA 94143 USA;

    Univ Pittsburgh, Chem Divers Ctr, Pittsburgh, PA 15260 USA;

    Leidos Biomed Res Inc, Frederick, MD 21702 USA;

    NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA;

    Univ Calif San Francisco, Sch Pharm, Small Mol Discovery Ctr, Pharmaceut Chem, San Francisco, CA 94143 USA;

    Univ Pittsburgh, Chem Divers Ctr, Pittsburgh, PA 15260 USA;

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

    CALTECH, Div Biol & Biol Engn, Pasadena, CA 91107 USA|CALTECH, Howard Hughes Med Inst, Pasadena, CA 91107 USA;

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

    Univ Pittsburgh, Chem Divers Ctr, Pittsburgh, PA 15260 USA;

    Univ Calif San Francisco, Sch Pharm, Small Mol Discovery Ctr, Pharmaceut Chem, San Francisco, CA 94143 USA;

    NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:35

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号